Over the last few years, several regulatory authorities, such as the FDA and EMA, reported the incidence of mood alterations, depressive symptoms, and even suicidal thoughts with the use of GLP-1 receptor agonists during the pharmacovigilance surveillance process, which raises the issue of their psychiatric safety [13,14,15]
Cette approche permet nos partenaires de maximiser leur rentabilit tout en livrant des supplments AdvaLife de qualit suprieure leurs clients
Purification and Characterization of Two Glutathione S-Aryltransferase Activities from Rat Liver
DeForte and Uversky, 2016)
9 Reduction in "Food Noise": As mentioned earlier, the ability of GLP-1s to act on the brain and reduce the constant, intrusive thoughts about food ("food noise") is a significant benefit for many